NEUROCRINE BIOSCIENCES INC Increase (Decrease) in Restricted Cash
NEUROCRINE BIOSCIENCES INC (NBIX) reported Increase (Decrease) in Restricted Cash of -$383.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2018-02-13
- NEUROCRINE BIOSCIENCES INC increase (decrease) in restricted cash for the quarter ending 2017-12-31 was -$113.00K.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in restricted cash for the quarter ending 2017-09-30 was $0.00.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in restricted cash for the quarter ending 2017-06-30 was -$470.00K.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in restricted cash for the quarter ending 2017-03-31 was $200.00K, a 0.00% change year-over-year.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in restricted cash for fiscal 2017 was -$383.00K, a 516.30% decline from fiscal 2016.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in restricted cash for fiscal 2016 was $92.00K.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in restricted cash for fiscal 2015 was -$40.00K, a 110.31% decline from fiscal 2014.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in restricted cash for fiscal 2014 was $388.00K, a 259.26% increase from fiscal 2013.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 6 month as first filed | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|---|
| 2017-12-31 | -$113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$113.00K derived: sum of 2 quarters · filed 2018-02-13 | -$583.00K derived: sum of 3 quarters · filed 2018-02-13 | -$383.00K 10-K · filed 2018-02-13 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$470.00K derived: sum of 2 quarters · filed 2017-11-01 | -$270.00K 10-Q · filed 2017-11-01 | -$270.00K derived: sum of 4 quarters · filed 2018-02-13 | |
| 2017-06-30 | -$470.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$270.00K 10-Q · filed 2017-08-03 | -$270.00K derived: sum of 3 quarters · filed 2018-02-13 | -$270.00K derived: sum of 4 quarters · filed 2018-02-13 | |
| 2017-03-31 | $200.00K 10-Q · filed 2017-05-09 | $200.00K derived: sum of 2 quarters · filed 2018-02-13 | $200.00K derived: sum of 3 quarters · filed 2018-02-13 | $92.00K derived: sum of 4 quarters · filed 2018-02-13 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $0.00 derived: sum of 2 quarters · filed 2018-02-13 | -$108.00K derived: sum of 3 quarters · filed 2018-02-13 | $92.00K 10-K · filed 2018-02-13 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$108.00K derived: sum of 2 quarters · filed 2017-11-01 | $92.00K 10-Q · filed 2017-11-01 | $92.00K derived: sum of 4 quarters · filed 2018-02-13 | |
| 2016-06-30 | -$108.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $92.00K 10-Q · filed 2017-08-03 | $92.00K derived: sum of 3 quarters · filed 2018-02-13 | $68.00K derived: sum of 4 quarters · filed 2018-02-13 | |
| 2016-03-31 | $200.00K 10-Q · filed 2017-05-09 | $200.00K derived: sum of 2 quarters · filed 2018-02-13 | $176.00K derived: sum of 3 quarters · filed 2018-02-13 | $160.00K derived: sum of 4 quarters · filed 2018-02-13 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$24.00K derived: sum of 2 quarters · filed 2018-02-13 | -$40.00K derived: sum of 3 quarters · filed 2018-02-13 | -$40.00K 10-K · filed 2018-02-13 | |
| 2015-09-30 | -$24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$40.00K derived: sum of 2 quarters · filed 2016-11-02 | -$40.00K 10-Q · filed 2016-11-02 | $348.00K derived: sum of 4 quarters · filed 2017-02-14 | |
| 2015-06-30 | -$16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$16.00K 10-Q · filed 2016-08-03 | $372.00K derived: sum of 3 quarters · filed 2017-02-14 | $372.00K derived: sum of 4 quarters · filed 2017-02-14 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-05 | $388.00K derived: sum of 2 quarters · filed 2017-02-14 | $388.00K derived: sum of 3 quarters · filed 2017-02-14 | ||
| 2014-12-31 | $388.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $388.00K derived: sum of 2 quarters · filed 2017-02-14 | $388.00K 10-K · filed 2017-02-14 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $0.00 10-Q · filed 2015-10-29 | |||
| 2014-06-30 | $0.00 10-Q · filed 2015-07-29 | ||||
| 2013-12-31 | $108.00K 10-K · filed 2016-02-11 | ||||
| 2013-06-30 | -$32.00K 10-Q · filed 2014-08-06 | ||||
| 2012-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-09 | $54.00K derived: sum of 2 quarters · filed 2015-02-09 | $29.00K 10-K · filed 2015-02-09 | ||
| 2012-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | $28.00K 10-Q · filed 2013-10-29 | |||
| 2012-06-30 | -$25.00K 10-Q · filed 2013-07-26 | $28.00K 10-Q · filed 2012-07-31 | |||
| 2011-12-31 | -$1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | -$1.80M derived: sum of 2 quarters · filed 2014-02-11 | -$1.80M derived: sum of 3 quarters · filed 2014-02-11 | -$1.80M 10-K · filed 2014-02-11 | |
| 2011-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | $24.00K derived: sum of 2 quarters · filed 2012-10-31 | $26.00K 10-Q · filed 2012-10-31 | -$205.00K derived: sum of 4 quarters · filed 2013-02-08 | |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-31 | $2.00K 10-Q · filed 2012-07-31 | -$229.00K derived: sum of 3 quarters · filed 2013-02-08 | -$225.00K derived: sum of 4 quarters · filed 2013-02-08 | |
| 2011-03-31 | $2.00K 10-Q · filed 2012-05-02 | -$229.00K derived: sum of 2 quarters · filed 2013-02-08 | -$225.00K derived: sum of 3 quarters · filed 2013-02-08 | ||
| 2010-12-31 | -$231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-08 | -$227.00K derived: sum of 2 quarters · filed 2013-02-08 | -$223.00K 10-K · filed 2013-02-08 | ||
| 2010-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $8.00K 10-Q · filed 2011-10-31 | |||
| 2010-06-30 | $4.00K 10-Q · filed 2011-07-29 | ||||
| 2009-12-31 | -$84.00K 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |